Background: Vav is a guanine-nucleotide exchange factor for the Rho-li
ke small GTPases RhoA, Rac1 and Cdc42, which regulate cytoskeletal reo
rganization and activation of stress-activated protein kinases (SAPK/J
NKs). Vav is expressed in hematopoietic cells and is phosphorylated in
T and B cells following activation of various growth factor or antige
n receptors. Vav interacts with several signaling molecules in T cells
, but the functional relevance of these interactions is established on
ly for Slp76: they cooperate to induce activity of the transcription f
actor NF-AT and interleukin-2 expression. We have investigated the rol
e of Vav in T cells by generating vav(-/-)mice. Results: Mice deficien
t for vav were viable and healthy, but had impaired T-cell development
. In vav(-/-) T cells, in response to activation of the T-cell recepto
r (TCR), cell cycle progression, induction of NF-ATc1 activity, downre
gulation of the cell-cycle inhibitor p27(Kip1) interleukin-2 productio
n, actin polymerization and the clustering of TCRs into patches and ca
ps - a cytoskeletal reorganization process - were defective. TCR-media
ted activation of mitogen-activated protein kinase and SAPK/JNK was un
affected. Ca2+ mobilization was impaired in vav(-/-) thymocytes and T
cells. In wild-type cells, Vav constitutively associated with the cyto
skeletal membrane anchors talin and vinculin. In the absence of Vav, p
hosphorylation of Slp76, Slp76-talin interactions, and recruitment of
the actin cytoskeleton to the CD3 xi chain of the TCR co-receptor were
impaired. Conclusions: Vav is a crucial regulator of TCR-mediated Ca2
+ flux, cytoskeletal reorganization and TCR clustering, and these are
required for T-cell maturation, interleukin-e production and cell cycl
e progression. (C) Current Biology Ltd ISSN 0960-9822.